ArticleTranslational cancer research2026
A bibliometric analysis of global research in cervical cancer radiotherapy (2015-2024): trends, hotspots, and future directions.
Article in Translational cancer research, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
3 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
Background: Despite the growing volume of cervical cancer (CC) research, few bibliometric studies have specifically focused on the recent landscape of radiotherapy-a critical treatment modality. This study aims to examine the global research landscape, thematic focus areas, and emerging trends in CC radiotherapy from 2015 to 2024 through a bibliometric and visual analysis. Methods: Relevant literature published from January 1, 2015, to December 31, 2024, was retrieved from the Web of Science Core Collection. Eligible publications were subjected to bibliometric analysis using VOSviewer, CiteSpace, and Bibliometrix R software. Results: A total of 1,496 publications met the inclusion criteria. The annual publication output demonstrated a general trend of fluctuating growth, with a slight decline in recent years. The highest contributions originated from China, the United States, and Japan. Leading institutions in terms of publication volume included the Chinese Academy of Medical Sciences, The University of Texas MD Anderson Cancer Center, and Tata Memorial Hospital, India. Gynecologic Oncology was identified as the most productive journal. Among individual contributors, Mahantshetty Umesh was associated with the highest number of publications and total citations. Co-citation analysis, keyword co-occurrence, and thematic clustering highlighted major research focuses, including advancements in radiotherapy technology, mechanisms of radioresistance, neoadjuvant chemotherapy, immunotherapy combinations, patient quality of life, socioeconomic disparities, and treatment accessibility. Conclusions: Significant advancements have been made in CC radiotherapy research over the past decade. Current and emerging research priorities include enhancing precision in radiotherapy, individualizing treatment strategies, elucidating mechanisms of radio resistance in CC cells, integrating chemoradiotherapy with immunotherapy, and evaluating radiotherapy-related quality of life outcomes.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.